Physician profile
Vanessa Christopher
NPI 1134615693
$1,146.91
in general payments reported to CMS, 2019-2025
7 companies · $195 in 2025
The $195 reported for 2025 was less than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $20.80 · 2021: $21.43 · 2022: $31.84 · 2023: $291 · 2024: $587 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,072.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $420.22 | 2023-2024 | |
| Revance Therapeutics, INC. | $304.91 | 2024 | Daxxify |
| Integra Lifesciences Corporation | $167.31 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Galderma Laboratories, L.P. | $161.85 | 2025 | |
| Depuy Synthes Sales INC. | $42.23 | 2020-2021 | |
| Stryker Corporation | $33.08 | 2025 | Sonopet Iq |
| Acclarent, INC | $17.31 | 2023 | Relieva Spinplus, Trudi Nav Cable |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vanessa Christopher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.